Hypoparathyroidism in children

Diseases of the Parathyroid Glands

Volumn 9781441955500, Issue , 2012, Pages 299-310

  Lienhardt Roussie, Anne ^a   Linglart, Agnès ^b  

^a National Reference Center for Calcium Phosphorus Metabolic Diseases   (France)

^b INSERM   (France)

Author keywords

1,25 Dihydroxy vitamin D; Acquired hypoparathyroidism; Activating and inhibiting mutations; Acute pancreatitis; Alfacalcidol; Aluminum hydroxide; Antiepileptic drugs; APECED syndrome; Autosomal dominant hypoparathyroidism; Basal ganglia; Behavioral problems; Calcifications of basal ganglia; Calcium chelators; Calcium receptor antibodies; Calcium sensing receptors; Cardioversion disturbances; Chemotherapy; Chvostek sign; Cleft palate; Currently; Cytochrome P450; Deafness; Deficiency of PTH production; Dental hypoplasia; DiGeorge syndrome; Distal renal tubular reabsorption; Dysmorphism; Embryological development; Exogenous PTH; Familial hypoparathyroidism X linked length recessive transmission; FARR syndrome; Fluorescent in situ hybridization; G protein coupled receptors; Glial cell missing B transcription factor; Heart is normal dominant hypocalcemia; Hypertelorism; Hypocalcemia; Hypomagnesemia; Hypoparathyroidism; Iatrogenic causes of hypocalcemia; Immunological disorders; Increased urinary calcium excretion; Infectious syndromes; Invasive tumors; Ionized calcium; Kearns Sayre syndrome; Kenny Caffey syndrome; Ketoconazole; Laryngospasm; Laxatives; Lithiasis; Maternal hyperparathyroidism and neonatal hypoparathyroidism; Mental retardation; Metaphysis; Microcephaly; Micrognathia; Mitochondrial disease; Mutation in PTH gene; NA LP 5 protein; Nephrocalcinosis; Neuromuscular irritability; Osteosarcoma; Parathyroid hormone; Paresthesias; Philtrum; Phosphatemia; Pseudo Bartter syndrome; Psychological manifestations; Radiological signs; Renal 1 alpha hydroxylase; Renal dysplasia syndrome; Retardation; Rhabdomyolysis; Sanjad Sakati syndrome; Seizures; Septic shock; SOX3; Surgery; TBX.1 gene; Teriparatide; Thymic aplasia; Transcription factors; Treatment; Trousseau sign; Urinary calcium; Urogenital, skeletal, ocular malformations

Indexed keywords

EID: 84927747207     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4419-5550-0_16     Document Type: Chapter

References (48)

1. Abugassa S, Nordenström J, Eriksson S, Sjödén G. Bone mineral density in patients with chronic hypoparathyroidism. J Clin Endocrinol Metab. 1993; 76: 1617-21
2. Fukunaga M, Otsuka N, Ono S, Kajihara Y, Nishishita S, Nakano Y, Yamamoto I, Torizuka K, Morita R. Computed tomography of basal ganglia calcifi cations in pseudo- And idiopathic hypoparathyroidism. Radiat Med. 1987; 5: 187-90
3. Gordon J, Bennett AR, Blackburn CC, Manley NR. Gcm2 and Foxn1 mark early parathyroid- And thymus-specifi c domains in the developing third pharyngeal pouch. Mech Dev. 2001; 103: 141-3
4. Iascone MR, Vittorini S, Sacchelli M, Spadoni I, Simi P, Giusti S. Molecular characterization of 22q11 deletion in a three-generation family with maternal transmission. Am J Med Genet. 2002; 108: 319-21
5. Merscher S, Funke B, Epstein JA, Heyer J, Puech A, Lu MM, Xavier RJ, Demay MB, Russell RG, Factor S, Tokooya K, Jore BS, Lopez M, Pandita RK, Lia M, Carrion D, Xu H, Schorle H, Kobler JB, Scambler P, Wynshaw-Boris A, Skoultchi AI, Morrow BE, Kucherlapati R. TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome. Cell. 2001; 104: 619-29
6. Yagi H, Furutani Y, Hamada H, Sasaki T, Asakawa S, Minoshima S, Ichida F, Joo K, Kimura M, Imamura S, Kamatani N, Momma K, Takao A, Nakazawa M, Shimizu N, Matsuoka R. Role of TBX1 in human del22q11.2 syndrome. Lancet Engl. 2003; 362(9393): 1366-73
7. Van Esch H, Groenen P, Nesbit M, Schuffenhauer S, Lichtner P, Vanderlinden G, Harding B, Beetz R, Bilous R, Holdaway I, Shaw N, Fryns J, Van de Ven W, Thakker R, Devriendt K. GATA3 haplo-insuffi -ciency causes human HDR syndrome. Nature. 2000; 406: 419-22
8. Kobrynski LJ, Sullivan KE. Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11.2 deletion syndromes. Lancet. 2007; 370: 1443-52
9. Paylor R, Glaser B, Mupo A, Ataliotis P, Spencer C, Sobotka A, Sparks C, Choi CH, Oghalai J, Curran S, Murphy KC, Monks S, Williams N, O'Donovan MC, Owen MJ, Scambler PJ, Lindsay E. Tbx1 haploinsuffi ciency is linked to behavioral disorders in mice and humans: implications for 22q11 deletion syndrome. Proc Natl Acad Sci USA. 2006; 103: 7729-34
10. Momma K. Cardiovascular anomalies associated with chromosome 22q11.2 deletion syndrome. Am J Cardiol. 2010; 105: 1617-24
11. Prasad SE, Howley S, Murphy KC. Candidate genes and the behavioral phenotype in 22q11.2 deletion syndrome. Dev Disabil Res Rev. 2008; 14: 26-34
12. Ding C, Buckingham B, Levine MA. Familial isolated hypoparathyroidism caused by a mutation in the gene for the transcription factor GCMB. J Clin Invest. 2001; 108: 1215-20
13. Mannstadt M, Bertrand G, Muresan M, Weryha G, Leheup B, Pulusani SR, Grandchamp B, Jüppner H, Silve C. Dominant-negative GCMB mutations cause an autosomal dominant form of hypoparathyroidism. J Clin Endocrinol Metab. 2008; 93: 3568-76
14. Thomée C, Schubert SW, Parma J, Lê PQ, Hashemolhosseini S, Wegner M, Abramowicz MJ. GCMB mutation in familial isolated hypoparathyroidism with residual secretion of parathyroid hormone. J Clin Endocrinol Metab. 2005; 90: 2487-92
15. Liu Z, Yu S, Manley NR. Gcm2 is required for the differentiation and survival of parathyroid precursor cells in the parathyroid/thymus primordia. Dev Biol. 2007; 305: 333-46
16. Kebebew E, Peng M, Wong MG, Ginzinger D, Duh QY, Clark OH. GCMB gene, a master regulator of parathyroid gland development, expression, and regulation in hyperparathyroidism. Surgery. 2004; 136: 1261-6
17. Ali A, Christie PT, Grigorieva IV, Harding B, Van Esch H, Ahmed SF, Bitner-Glindzicz M, Blind E, Bloch C, Christin P, Clayton P, Gecz J, Gilbert-Dussardier B, Guillen-Navarro E, Hackett A, Halac I, Hendy GN, Lalloo F, Mache CJ, Mughal Z, Ong AC, Rinat C, Shaw N, Smithson SF, Tolmie J, Weill J, Nesbit MA, Thakker RV. Functional characterization of GATA3 mutations causing the hypoparathyroidism-deafness-renal (HDR) dysplasia syndrome: insight into mechanisms of DNA binding by the GATA3 transcription factor. Hum Mol Genet. 2007; 16: 265-75
18. Benetti E, Murer L, Bordugo A, Andreetta B, Artifoni L. 10p12.1 Deletion: HDR phenotype without DGS2 features. Exp Mol Pathol. 2009; 86: 74-6
19. Nesbit MA, Bowl MR, Harding B, Ali A, Ayala A, Crowe C, Dobbie A, Hampson G, Holdaway I, Levine MA, McWilliams R, Rigden S, Sampson J, Williams AJ, Thakker RV. Characterization of GATA3 mutations in the hypoparathyroidism, deafness, and renal dysplasia (HDR) syndrome. J Biol Chem. 2004; 279: 22624-34
20. Bernardini L, Sinibaldi L, Capalbo A, Bottillo I, Mancuso B, Torres B, Novelli A, Digilio MC, Dallapiccola B. HDR (hypoparathyroidism, deafness, renal dysplasia) syndrome associated to GATA3 gene duplication. Clin Genet. 2009; 76: 117-9
21. Parvari R, Diaz GA, Hershkovitz E. Parathyroid development and the role of tubulin chaperone E. Horm Res. 2007; 67: 12-21
22. Courtens W, Wuyts W, Poot M, Szuhai K, Wauters J, Reyniers E, Eleveld M, Diaz G, Nöthen MM, Parvari R. Hypoparathyroidism-retardation-dysmorphism syndrome in a girl: a new variant not caused by a TBCE mutation - clinical report and review. Am J Med Genet A. 2006; 140: 611-7
23. Hershkovitz E, Parvari R, Diaz GA, Gorodischer R. Hypoparathyroidism-retardation-dysmorphism (HRD) syndrome - A review. J Pediatr Endocrinol Metab. 2004; 17: 1583-90
24. Bowl MR, Nesbit MA, Harding B, Levy E, Jefferson A, Volpi E, Rizzoti K, Lovell-Badge R, Schlessinger D, Whyte MP, Thakker RV. An interstitial deletion-insertion involving chromosomes 2p25.3 and Xq27.1, near SOX3, causes X-linked recessive hypoparathyroidism. J Clin Invest. 2005; 115: 2822-31
25. Thakker RV. Diseases associated with the extracellular calcium-sensing receptor. Cell Calcium. 2004; 35: 275-82
26. Lienhardt A, Bai M, Lagarde JP, Rigaud M, Zhang Z, Jiang Y, Kottler ML, Brown EM, Garabédian M. Activating mutations of the calcium-sensing receptor: management of hypocalcemia. J Clin Endocrinol Metab. 2001; 86: 5313-23
27. Lienhardt A, Garabédian M, Bai M, Sinding C, Zhang Z, Lagarde JP, Boulesteix J, Rigaud M, Brown EM, Kottler ML A large homozygous or heterozygous inframe deletion within the calcium-sensing receptor's carboxylterminal cytoplasmic tail that causes autosomal dominant hypocalcemia. J Clin Endocrinol Metab. 2000; 85: 1695-702
28. Gamba G, Friedman PA. Thick ascending limb: the Na(+): K (+): 2Cl (-) co-Transporter, NKCC2, and the calcium-sensing receptor, CaSR. Pfl ugers Arch. 2009; 458: 61-76
29. Watanabe S, Fukumoto S, Chang H, Takeuchi Y, Hasegawa Y, Okazaki R, Chikatsu N, Fujita T. Association between activating mutations of calciumsensing receptor and Bartter's syndrome. Lancet. 2002; 360: 692-4
30. Ahn TG, Antonarakis SE, Kronenberg HM, Igarashi T, Levine MA. Familial isolated hypoparathyroidism: a molecular genetic analysis of 8 families with 23 affected persons. Medicine (Baltimore). 1986; 65: 73-81
31. Arnold A, Horst SA, Gardella TJ, Baba H, Levine MA, Kronenberg HM. Mutation of the signal peptideencoding region of the preproparathyroid hormone gene in familial isolated hypoparathyroidism. J Clin Invest. 1990; 86: 1084-7
32. D'Amour P, Palardy J, Bahsali G, Mallette LE, DeLean A, Lepage R The modulation of circulating parathyroid hormone immunoheterogeneity in man by ionized calcium concentration. J Clin Endocrinol Metab. 1992; 74: 525-32
33. Katsanos KH, Elisaf M, Bairaktari E, Tsianos EV. Severe hypomagnesemia and hypoparathyroidism in Kearns-Sayre syndrome. Am J Nephrol. 2001; 21: 150-3
34. Wilichowski E, Grüters A, Kruse K, Rating D, Beetz R, Korenke GC, Ernst BP, Christen HJ, Hanefeld F. Hypoparathyroidism and deafness associated with pleioplasmic large scale rearrangements of the mitochondrial DNA: a clinical and molecular genetic study of four children with Kearns-Sayre syndrome. Pediatr Res. 1997; 41: 193-200
35. Brown EM. Anti-parathyroid and anti-calcium sensing receptor antibodies in autoimmune hypoparathyroidism. Endocrinol Metab Clin N Am. 2009; 38: 437-45. x.
36. Mayer A, Ploix C, Orgiazzi J, Desbos A, Moreira A, Vidal H, Monier JC, Bienvenu J, Fabien N. Calciumsensing receptor autoantibodies are relevant markers of acquired hypoparathyroidism. J Clin Endocrinol Metab. 2004; 89: 4484-8
37. Gardner JM, Fletcher AL, Anderson MS, Turley SJ. AIRE in the thymus and beyond. Curr Opin Immunol. 2009; 21: 582-9
38. Wolff AS, Erichsen MM, Meager A, Magitta NF, Myhre AG, Bollerslev J, Fougner KJ, Lima K, Knappskog PM, Husebye ES. Autoimmune polyendocrine syndrome type 1 in Norway: phenotypic variation, autoantibodies, and novel mutations in the autoimmune regulator gene. J Clin Endocrinol Metab. 2007; 92: 595-603
39. Alimohammadi M, Björklund P, Hallgren A, Pöntynen N, Szinnai G, Shikama N, Keller MP, Ekwall O, Kinkel SA, Husebye ES, Gustafsson J, Rorsman F, Peltonen L, Betterle C, Perheentupa J, Akerström G, Westin G, Scott HS, Holländer GA, Kämpe O. Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen. N Engl J Med. 2008; 358: 1018-28
40. Alimohammadi M, Dubois N, Sköldberg F, Hallgren A, Tardivel I, Hedstrand H, Haavik J, Husebye ES, Gustafsson J, Rorsman F, Meloni A, Janson C, Vialettes B, Kajosaari M, Egner W, Sargur R, Pontén F, Amoura Z, Grimfeld A, De Luca F, Betterle C, Perheentupa J, Kämpe O, Carel JC. Pulmonary autoimmunity as a feature of autoimmune polyendocrine syndrome type 1 and identifi cation of KCNRG as a bronchial autoantigen. Proc Natl Acad Sci USA. 2009; 106: 4396-401
41. Page C, Strunski V. Parathyroid risk in total thyroidectomy for bilateral, benign, multinodular goitre: report of 351 surgical cases. J Laryngol Otol. 2007; 121: 237-41
42. Lienhardt-Roussie A, Linglart A, Garabedian M. Treatment of chronic hypocalcaemia during childhood. Arch Pediatr. 2008; 15: 650-2
43. Misselwitz J, Hesse V, Markestad T. Nephrocalcinosis, hypercalciuria and elevated serum levels of 1,25-dihydroxyvitamin D in children. Possible link to vitamin D toxicity. Acta Paediatr Scand. 1990; 79: 637-43
44. Weber G, Cazzuffi MA, Frisone F, de Angelis M, Pasolini D, Tomaselli V, Chiumello G. Nephrocalcinosis in children and adolescents: sonographic evaluation during long-Term treatment with 1,25-dihydroxycholecalciferol. Child Nephrol Urol. 1988; 9: 273-6
45. Winer KK, Sinaii N, Peterson D, Sainz B, Cutler GB. Effects of once versus twice-daily parathyroid hormone 1-34 therapy in children with hypoparathyroidism. J Clin Endocrinol Metab. 2008; 93: 3389-95
46. Linglart A, Rothenbuhler A, Gueorgieva I, Lucchini P, Silve C, Bougnères P. Long-Term results of continuous subcutaneous recombinant PTH (1-34) infusion in children with refractory hypoparathyroidism. J Clin Endocrinol Metab. 2011; 96(11): 3308-12
47. Subbiah V, Madsen VS, Raymond AK, Benjamin RS, Ludwig JA. Of mice and men: divergent risks of teriparatide-induced osteosarcoma. Osteoporos Int. 2010; 21: 1041-5
48. Theman TA, Collins MT, Dempster DW, Zhou H, Reynolds JC, Brahim JS, Roschger P, Klaushofer K, Winer KK. PTH(1-34) replacement therapy in a child with hypoparathyroidism caused by a sporadic calcium receptor mutation. J Bone Miner Res. 2009; 24: 964-73